SMTL ID : 7seg.2 (1 other biounit)

Crystal structure of the complex of CD16A bound by an anti-CD16A Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.16 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain C: H.47, N.48, V.66, D.67, S.69 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:D.67

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain C: L.160, N.165 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:L.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kakiuchi-Kiyota, S. et al., A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma. Leukemia (2022)

Release Date

2021-11-24

Peptides

anti-CD16a Fab light chain: A
anti-CD16A Fab heavy chain: B
Low affinity immunoglobulin gamma Fc region receptor III-A: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
A

C
D

anti-CD16a Fab light chain

anti-CD16A Fab heavy chain

Low affinity immunoglobulin gamma Fc region receptor III-A

Related Entries With Identical Sequence